Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Remedium Bio
Entity

Remedium Bio

Tracked across 1 events · 6 articles · First seen Aug 10, 2026 · Last active Aug 10, 2026

Sentiment
70
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 70
Business
Lifespan Vision Leads Remedium Bio Series A
Lifespan Vision Ventures announced it is leading a $10 million Series A financing for Remedium Bio, Inc., a biotechnology company developing durable protein therapeutics. The round's initial closing has been completed with participation from Eli…
Impact: Recipient of $10 million Series A financing, enabling advancement of its durable protein therapeutics platform toward clinical trials, boosting its development prospects.
Aug 10, 2026 · 6 articles
Key Actions (3)
70 Eli Lilly and Company participated in financing Remedium BioLifespan Vision Leads...
70 HKX Capital participated in financing Remedium BioLifespan Vision Leads...
40 Harry Robb joined board Remedium BioLifespan Vision Leads...
ERGEN INTELLIGENCE
Track Remedium Bio live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.